Skip to main
HCA

HCA Healthcare (HCA) Stock Forecast & Price Target

HCA Healthcare (HCA) Analyst Ratings

Based on 20 analyst ratings
Buy
Strong Buy 35%
Buy 30%
Hold 30%
Sell 5%
Strong Sell 0%

Bulls say

HCA Healthcare is well-positioned to continue its growth and profitability in the healthcare industry due to its strong management team, leading market share, and robust financial flexibility. With its focus on expanding access to care for communities and diverse patient population, as well as its impressive margins and solid track record, the company is poised for success. While there are risks to consider such as competition, reimbursement changes, and potential investigations, HCA's scale, diversified business mix, and strong cash flow generation give it a competitive advantage.

Bears say

HCA Healthcare is well positioned in the growing U.S. healthcare market, but may face sustainability issues with waste and energy consumption. The company's strong track record of operational performance, resiliency initiatives, and financial flexibility provide opportunities for long-term growth, but potential headwinds from increased costs, patient mix shifts, and payor denial could impact near-term financials and upside potential. Overall, while the company maintains a solid market position, concerns over sustainability and potential challenges lead to a negative outlook on their stock.

HCA Healthcare (HCA) has been analyzed by 20 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 30% recommend Buy, 30% suggest Holding, 5% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HCA Healthcare (HCA) Forecast

Analysts have given HCA Healthcare (HCA) a Buy based on their latest research and market trends.

According to 20 analysts, HCA Healthcare (HCA) has a Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $471.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $471.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HCA Healthcare (HCA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.